MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
NVIDIA
NVDA
US Stock MarketDetailed Quotes
YMAB Y-mAbs Therapeutics
- 8.150
- +0.180+2.26%
Trading Jan 3 12:41 ET
365.03MMarket Cap-15.09P/E (TTM)
8.240High7.980Low52.29KVolume8.000Open7.970Pre Close426.14KTurnover0.19%Turnover RatioLossP/E (Static)44.79MShares20.90052wk High3.95P/B220.66MFloat Cap6.92152wk Low--Dividend TTM27.07MShs Float55.215Historical High--Div YieldTTM3.26%Amplitude2.700Historical Low8.150Avg Price1Lot Size
Y-mAbs Therapeutics News
Y-mAbs Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Y-mAbs Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.56%)
Y-mAbs Therapeutics | 10-Q: Q3 2024 Earnings Report
Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
Y-mAbs Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.56%)
Y-mAbs Therapeutics | 8-K: Current report
Y-mAbs Therapeutics | UPLOAD: Others
Y-mAbs Therapeutics | CORRESP: CORRESP
Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gad Thomas
Y-mAbs Therapeutics | 8-K: Current report
Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gad Thomas
Y-mAbs Therapeutics | 8-K: Current report
Y-mAbs Therapeutics | UPLOAD: Others
Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lund-Hansen Torben
Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Y-mAbs Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilms Joris
Y-mAbs Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Y-mAbs Therapeutics | 10-Q: Q2 2024 Earnings Report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.